AzTrials
AzTrials

Sexual HarassmentE-STOPNCT06171633

Ending Sexual Harassment - Teaching Of Principal Investigators

A study testing E-STOP online educational program (treatment condition) in people with Sexual Harassment, run by Stanford University at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The study targets three aims: Aim 1: focuses on PIs' and mentors' confidence in their ability to intervene on sexual harassment and their attitudes, perceptions, and knowledge (APK) about sexual harassment, civility, microaggressions, and unconscious bias. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sexual Harassment
What is being tested?
E-STOP online educational program (treatment condition)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,160 participants
Where
1 siteUnited States
Study dates
6 Mar 2024to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • PIs, Mentors and Trainees of T-32 Programs

Who cannot join

  • People who are not PIs, Mentors and Trainees of T-32 Programs

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site

  • Stanford University

    Stanford, California, 94305

Other trials in United States

About this study

The study targets three aims: Aim 1: focuses on PIs' and mentors' confidence in their ability to intervene on sexual harassment and their attitudes, perceptions, and knowledge (APK) about sexual harassment, civility, microaggressions, and unconscious bias. Aim 2: focuses on trainees' experiences of sexual harassment and microaggressions and civility, sense of belonging, well-being, productivity, and persistence in a research career. Aim 3: focuses on the culture and climate of the research learning environment.

Read the detailed description

Participants (PIs, mentors, and trainees), starting in year one, will be asked to complete a baseline survey (using the secure survey software Qualtrics) regardless of condition assignment. Then, for several months, PIs, mentors, and mentees will receive virtual educational materials (presented using a Learning Management System) appropriate to the condition to which their program has been randomized.

The initial post-survey for PIs and mentors will be shortly after the final module to evaluate short-term outcomes, encompassing attitudes, perceptions, and knowledge. Subsequently, the second post-survey will be administered one year later. Trainees will participate in three post-surveys: one immediately after, another one year later, and a final one two years later.

Being tested
E-STOP online educational program (treatment condition), E-STOP online educational program (control condition)
Keywords
Sexual Harassment Prevention, Educational Online Training, Video Game Elements, Upstanding
Medical subject headings
Sexual Harassment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • E-STOP online educational program (treatment condition)Behavioural

    Participants access online video modules through an online learning platform. Program includes modules on civility and upstander interventions and education about sexual harassment, microaggressions, and implicit bias.

  • E-STOP online educational program (control condition)Behavioural

    Participants access online video modules through an online learning platform. Program includes authorship ethics only.

Study groups in NCT06171633
Study groupRoleWhat they receive
Intervention Group / year 1ExperimentalBeginning in year 1, participants access online video modules through an online learning platform for up to 9 months.
Receives: Behavioral: E-STOP online educational program (treatment condition)
Control Condition Group / year 1ExperimentalBeginning in year 1, participants access online video modules through an online learning platform for up to 9 months.
Receives: Behavioral: E-STOP online educational program (control condition)
Intervention Group / year 2ExperimentalBeginning in year 2, participants access online video modules through an online learning platform for up to 9 months.
Receives: Behavioral: E-STOP online educational program (treatment condition)
Control Condition Group / year 2ExperimentalBeginning in year 2, participants access online video modules through an online learning platform for up to 9 months.
Receives: Behavioral: E-STOP online educational program (control condition)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Confidence to Intervene on Sexual Harassment Scale Score

    Participants are asked to rate: "How confident are you in your ability to intervene when you hear about or witness sexual harassment?" Score range: 1 (not at all confident) to 5 (extremely confident).

    Measured: Survey at baseline, immediately post-intervention (9 months after baseline), and 1 year after the completion of the 9-month intervention

Secondary outcomes (2)

  1. Persistence in research careers

    Participants are asked to rate: "How extensively do you expect to be involved in research during your medical career?" Score range 1 (not involved) to 5 (exclusively)

    Measured: baseline, immediately post-intervention (9 months after baseline), and 1 year after completion of the 9-month intervention.

  2. Experiences of sexual harassment as measured by the short Sexual Experiences Questionnaire (SEQ-DoDs)

    The SEQ consists of 4 domains: gender harassment--sexist hostility (4 questions); gender harassment--sexual hostility (4 questions); unwanted sexual attention (4 questions); and sexual coercion (4 questions); the score for each question ranges from 1 (never) to 5 (many times); scores for questions within each domain are summed and divided by the number of questions, resulting in an average score range from 1 (never) to 5 (many times) for each domain.

    Measured: baseline, immediately post-intervention (9 months after baseline), and 1 year after completion of the 9-month intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2023
  2. Study start6 Mar 2024
  3. Primary completionJun 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2,160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06171633
Sponsor's protocol ID
66842
Other IDs
1R01GM147063
Acronym
E-STOP
Status last verified
Dec 2024
First submitted
6 Dec 2023
Last updated
29 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Torres MB, Salles A, Cochran A. Recognizing and Reacting to Microaggressions in Medicine and Surgery. JAMA Surg. 2019 Sep 1;154(9):868-872. doi: 10.1001/jamasurg.2019.1648.

    PubMed 31290954

  • Montanaro E, Fiellin LE, Fakhouri T, Kyriakides TC, Duncan LR. Using Videogame Apps to Assess Gains in Adolescents' Substance Use Knowledge: New Opportunities for Evaluating Intervention Exposure and Content Mastery. J Med Internet Res. 2015 Oct 28;17(10):e245. doi: 10.2196/jmir.4377.

    PubMed 26510775

  • Sompayrac L, Danna KJ. An SV40 mutant oncoprotein has a nuclear location. Virology. 1989 Jul;171(1):267-70. doi: 10.1016/0042-6822(89)90536-9.

    PubMed 2741344

  • Salles A, Mueller CM, Cohen GL. Exploring the Relationship Between Stereotype Perception and Residents' Well-Being. J Am Coll Surg. 2016 Jan;222(1):52-8. doi: 10.1016/j.jamcollsurg.2015.10.004. Epub 2015 Oct 21.

    PubMed 26616033

  • Fiellin LE, Hieftje KD, Pendergrass TM, Kyriakides TC, Duncan LR, Dziura JD, Sawyer BG, Mayes L, Crusto CA, Forsyth BW, Fiellin DA. Video Game Intervention for Sexual Risk Reduction in Minority Adolescents: Randomized Controlled Trial. J Med Internet Res. 2017 Sep 18;19(9):e314. doi: 10.2196/jmir.8148.

    PubMed 28923788

  • Mueller AS, Jenkins TM, Osborne M, Dayal A, O'Connor DM, Arora VM. Gender Differences in Attending Physicians' Feedback to Residents: A Qualitative Analysis. J Grad Med Educ. 2017 Oct;9(5):577-585. doi: 10.4300/JGME-D-17-00126.1.

    PubMed 29075375

  • Tenbrunsel AE, Rees MR, Diekmann KA. Sexual Harassment in Academia: Ethical Climates and Bounded Ethicality. Annu Rev Psychol. 2019 Jan 4;70:245-270. doi: 10.1146/annurev-psych-010418-102945. Epub 2018 Aug 29.

    PubMed 30156976

Questions about this trial

What is this clinical trial studying?

A study testing E-STOP online educational program (treatment condition) in people with Sexual Harassment, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 29 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Confidence to Intervene on Sexual Harassment Scale Score (time frame: Survey at baseline, immediately post-intervention (9 months after baseline), and 1 year after the completion of the 9-month intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06171633, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2025.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in